MUWRP VACCINE TRIALS

vaccine trialsCOMPLETED STUDIES

RV 156: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda. Site Principal Investigator: Fred Wabwire-Mangeni, MBChB, PhD. Collaborations: Vaccine study conducted by US military Research Program and Makerere University Walter Reed Project. Vaccines provides by Vaccine Research Centre VRC/NIAID/NIH Bethesda Maryland. Background and rationale: the global impact of the HIV epidemic is staggering. In developing countries and segments of the US population, anti-HIV therapies are frequently beyond financial reach. Read Full Publication Here

Comments are closed.